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Abstract
Streptococcus pneumoniae is an important human pathogen responsible for a spectrum of diseases including pneumonia.
Immunological and pro-inflammatory processes induced in the lung during pneumococcal infection are well documented,
but little is known about the role played by immunoregulatory cells and cytokines in the control of such responses. We
demonstrate considerable differences in the immunomodulatory cytokine transforming growth factor (TGF)-b between the
pneumococcal pneumonia resistant BALB/c and susceptible CBA/Ca mouse strains. Immunohistochemistry and flow
cytometry reveal higher levels of TGF-b protein in BALB/c lungs during pneumococcal pneumonia that correlates with a
rapid rise in lung Foxp3
+Helios
+ T regulatory cells. These cells have protective functions during pneumococcal pneumonia,
because blocking their induction with an inhibitor of TGF-b impairs BALB/c resistance to infection and aids bacterial
dissemination from lungs. Conversely, adoptive transfer of T regulatory cells to CBA/Ca mice, prior to infection, prolongs
survival and decreases bacterial dissemination from lungs to blood. Importantly, strong T regulatory cell responses also
correlate with disease-resistance in outbred MF1 mice, confirming the importance of immunoregulatory cells in controlling
protective responses to the pneumococcus. This study provides exciting new evidence for the importance of
immunomodulation during pulmonary pneumococcal infection and suggests that TGF-b signalling is a potential target
for immunotherapy or drug design.
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Introduction
Streptococcus pneumoniae (the pneumococcus) is an important
human pathogen that accounts for significant morbidity and
mortality, particularly in high-risk groups such as children, the
elderly and the immunocompromised. Determination of host
protective immune responses to pneumococcal infection is highly
desirable, not least because an improved understanding of the cellular
and molecular interactions of host and pathogen might enable the
design of specific, targeted therapies that are able to overcome the
limitations of current treatment and prevention strategies.
It has long been thought that neutrophils are the primary
mediators of early defence against pulmonary pneumococcal
infection [1–3] but more recently a key role for T cells in the
earliest stages of immunity against the pneumococcus has
emerged. It has been noted that T cells infiltrate the lungs of
intranasally-infected mice at an early time post-infection and that
the peak of infiltration coincides with a cessation in pneumococcal
growth in the lungs [4]. Furthermore, it has been demonstrated
that CD4
+ T cells contribute to protective immunity to invasive
pneumococcal pneumonia, as MHC-II-deficient mice, which have
severely reduced numbers of CD4
+ T cells, are highly susceptible
to infection [5]. However, whilst there is an expanding body of
work outlining the roles of inflammatory T cell subsets [6–9], little
has been made of regulatory and anti-inflammatory T cells and
their influence on the outcome of pneumococcal pneumonia. This
is an important gap in our understanding of the immunology of
pneumococcal disease.
Several immune cell types, including tolerogenic DCs [10],
myeloid suppressor cells [11], IL-10-producing CD4
+ T cells [12],
B cells [13] and Foxp3
+ T regulatory cells [14], have confirmed
roles in the modulation and inhibition of inflammation in the
context of infection. Of these immunomodulatory cells, Foxp3
+ T
regulatory cells are probably the best characterized. These cells
have emerged as essential components of the mammalian immune
system and play crucial roles in immune homeostasis as well as
limiting infection-associated inflammation and facilitating resolu-
tion of tissue damage post-infection [15,16]. Indeed, for West Nile
Virus, a link has been made between T regulatory cell activity and
symptomatic versus asymptomatic infection [17].
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cytokines and T regulatory cells during infection with S. pneumoniae,
but recent data suggest an importance of immunomodulation in
anti-pneumococcal responses. Intraperitoneal administration of S.
pneumoniae serotype 1 capsular polysaccharide induces CD8
+
CD28
2 T-cells with a regulatory phenotype [18] that synthesize
both IL-10 and TGF-b and are immunosuppressive for CD4
+ T
cells in vivo and in vitro. However, whether regulatory cells play
protective roles during infection with invasive S. pneumoniae strains
remained to be elucidated. Although it has previously been
observed that CD25
+ T cells are induced during pneumococcal
pneumonia [5] and that the administration of heat-killed S.
pneumoniae to mice can suppress allergic airway disease by the
induction of T regulatory cell expansion [19], the studies reported
in this paper now provide new evidence for the important
protective role performed by T regulatory cells in an in vivo model
of invasive pneumococcal pneumonia.
The need to address the role of immunomodulatory cells and
cytokines in pneumococcal infection is pressing, not least because
it is unclear at present whether their actions are protective or
detrimental to the outcome of infection. For example, IL-10 is a
cytokine produced by T regulatory cells that plays key protective
roles in limiting inflammation in a number of diseases through its
pleiotropic inhibitory effects on immune cells, but it has also been
shown to impair defense mechanisms in pneumococcal pneumo-
nia (albeit post influenza infection) [20]. In a recent study,
adenoidal cells from children testing positive for pneumococcal
carriage were found to contain higher numbers of Foxp3
+ T
regulatory cells than those taken from children without pneumo-
coccal carriage suggesting an immunosuppressive role for these
cells. Furthermore, in vitro, pneumococcal whole cell antigen
induced T regulatory cell proliferation and production of IL-10
[21]. In this paper, we have now addressed the role of T regulatory
cells in vivo during invasive pneumococcal pneumonia.
To determine the involvement of T regulatory cells and
immunomodulatory cytokines in resistance to pneumococcal
infection, we utilized two mouse strains that have strikingly
different susceptibility to pneumococcal pneumonia [22,23].
BALB/c mice are highly resistant to respiratory challenge against
a wide range of invasive pneumococci and confine their infection
to the lung (without developing sepsis) and then eliminate it within
7 days. By contrast, CBA/Ca mice succumb quickly to respiratory
infection, developing septicaemia and dying within 24 hours of
infection [22].
Linkage mapping of the offspring of BALB/c and CBA/Ca
intercrosses revealed a major locus on mouse chromosome 7, the
Spir1 (Streptococcus pneumoniae infection resistance 1) locus, that
influences survival after infection with S. pneumoniae [23]. The
Tgfb1 gene is located within this region of chromosome 7 and this
prompted us to investigate the contribution of TGF-b and its
downstream targets – including T regulatory cells - to the differing
susceptibilities of BALB/c and CBA/Ca mice to invasive
pneumococcal pneumonia. These studies have unearthed an
important but hitherto unappreciated role for T regulatory cells in
limiting immune-mediated damage in the lungs during pneumo-
coccal pneumonia. This is, to our knowledge, the first study
identifying a protective role for T regulatory cells during invasive
pneumonia and it is to be hoped that the findings herein may
facilitate the design of pneumococcal therapies aiming to improve
T regulatory cell responses in susceptible or infected individuals.
Results
TGF-b signaling is regulated differentially in BALB/c and
CBA/Ca mice during pneumococcal pneumonia
In a preliminary study, microarray comparison of gene
expression in lung tissue from BALB/c or CBA/Ca mice following
intranasal infection with S. pneumoniae indicated significant
differential regulation of the TGF-b signalling pathway between
the two strains (Figure 1). At 6 hours post-infection (p.i.) many of
the interaction partners of Tgfb1 showed opposing regulation in
BALB/c and CBA/Ca mice.
As TGF-b and many of its interaction partners are found within
the Spir1 susceptibility locus (Figure 1) [23], Tgfb1 was selected for
further analysis. qRT-PCR analysis was performed on lung tissue
from intranasally-infected BALB/c and CBA/Ca mice to
determine Tgfb1 expression over the course of pneumococcal
pneumonia. Strikingly, expression of Tgfb1 was significantly higher
in BALB/c than in CBA/Ca mice both before infection and at
6 hours p.i. (Figure 2 A and B).
To investigate whether the observed differences in Tgfb1 gene
expression were reflected in changes in TGF-b1 protein in the
lungs, immunohistochemical analysis was performed on lung
sections (Figure 2 C). A significant increase in the percentage of
epithelial cells staining TGF-b1
+ in the lungs of BALB/c mice, but
not CBA/Ca mice was observed between 0 and 6 hours p.i.
Interestingly, the percentage of TGF-b1
+ epithelial cells in BALB/
c lungs returned to pre-infection levels by 12 hours p.i., perhaps as
the result of cleavage of active TGF-b protein from the surface of
the cells. These data indicate a rapid and robust increase in TGF-
b1 synthesis and export by BALB/c airway epithelial cells in
response to infection, which is absent in CBA/Ca mice.
BALB/c mice display a greater expansion and recruitment
of Foxp3
+ cells to the lungs than do CBA/Ca mice during
pneumococcal pneumonia
T regulatory cells are both a source and a target of TGF-b,s o
the numbers and function of these cells were investigated in the
lungs of BALB/c and CBA/Ca mice before and during
pneumococcal infection. Staining of lung tissue sections for Foxp3
revealed no differences in the numbers of Foxp3
+ cells in the lungs
of uninfected CBA/Ca and BALB/c mice but substantially
Author Summary
Streptococcus pneumoniae is a major human bacterial
pathogen that causes a wide range of diseases including
pneumonia, meningitis, sepsis and ear infections. The
bacterium is responsible for around 1.2 million deaths per
year, mostly in high-risk groups such as children, the
elderly and those with a weakened immune system.
Infection with the pneumococcus can induce a wide-
variety of immune responses and disease symptoms and it
is not known why some people are more resistant to
infection than others. Here, we identify an important role
in natural resistance against pneumococcal pneumonia for
a group of cells – known as T regulatory cells – that control
the immune response to pneumococcal infection. In mice,
strong T regulatory cell responses correlate with resistance
to invasive pneumococcal pneumonia. Disease-resistance
can be boosted by administering T regulatory cells to
highly susceptible mice or inhibited by blocking the
activity of these cells in resistant mice. These results
advance our understanding of the host immunity differ-
ences that underpin resistance to pneumococcal pneu-
monia and offer hope that in the future we might boost
resistance in susceptible individuals through modulation
of their immune system.
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(p,0.05), with no significant changes apparent in the CBA/Ca
strain (Figure 3 A). The correlation between T regulatory cell
numbers and the effectiveness of the ongoing immune response in
the lung is readily apparent as bacterial CFUs in the lungs of
BALB/c mice fall rapidly by 24 hours p.i., while bacterial
numbers in CBA/Ca lungs increase over the same time period
despite similar CFUs for both mouse strains at 12 p.i. (Figure S1 A)
[22].
To further characterize the Foxp3
+ cells identified in the lungs
during pneumococcal infection, flow cytometry was performed on
lung cells from infected mice. Intracellular staining for Foxp3
confirmed the immunohistochemistry finding that whilst there was
no apparent difference in the number of T regulatory cells in the
lungs of uninfected BALB/c and CBA/Ca mice (Figure 3 B), by
24 hours p.i., T regulatory cell numbers had risen approximately
2.5-fold in the lungs of BALB/c mice (p,0.01) but remained
unchanged in CBA/Ca mice (p.0.05), as compared to uninfected
levels (Figure 3 B). This increase in T regulatory cell numbers also
correlate with significantly reduced CFUs in lungs of BALB/c
mice compared to CBA/Ca mice at equivalent time points (Figure
S1 A).
Regulatory T cells can develop in the thymus or from CD4
+ T
cells in the periphery. The thymus-derived cells are commonly
Figure 1. Many Tgfb1 interaction partners show opposing expression profiles in BALB/c and CBA/Ca mice at 6 hours p.i. Ingenuity
pathway analysis of microarray data from 6 hours p.i. Red=Gene significantly upregulated as compared to t=0 levels. Green=Down-regulated.
BALB/c levels are compared to BALB/c t=0 expression and CBA/Ca levels are compared to CBA/Ca t=0 expression. Orange outline=Gene found
within Spir1 susceptibility-determining locus. Solid lines indicate direct interactions, dotted lines indicate indirect interactions.
doi:10.1371/journal.ppat.1002660.g001
Figure 2. tgfb1 expression and TGF-b production is upregulated in BALB/c lungs in contrast to CBA/Ca lungs during pneumococcal
infection. Relative gene expression of tgfb1 in lungs of BALB/c and CBA/Ca mice before (A) and during (B) pneumococcal infection. Data were
normalised against a housekeeping gene (Hprt1) and are presented using BALB/c results as a calibrator (A) or else using BALB/c or CBA/Ca sham-
infection data from the appropriate time-point as calibrators (B). For 6 and 12 hours p.i. data for each strain was calibrated against sham-infection
data for that strain at the same time-point. i.e. BALB/c to BALB/c sham and CBA/Ca to CBA/Ca sham. (C) Antibody staining of TGF-b in airway
epithelial cells from BALB/c and CBA/Ca mice during pneumococcal infection. *=p,0.05, ***=p,0.005. For all figures data represent mean +/2
SEM. Data are representative of two independent experiments with 5 mice per time-point per strain and per treatment group.
doi:10.1371/journal.ppat.1002660.g002
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suggested that they can be distinguished from the cells developing in
theperiphery(inducedTregulatorycells;iTregs)bytheirexpression
of the Ikaros family transcription factor, Helios [24]. However,
more recently it has been observed that Helios is expressed on
activated T cells of all subsets and so is perhaps not suitable as an
nTreg marker [25]. Thus, in this study we have used Helios as a
marker for activated T regulatory cells. Analysis of Helios
expression in lung cells during our experiments revealed that the
increase in T regulatory cells in BALB/c lungs during pneumococ-
cal pneumonia was due to increased Helios
+ cells (Figure 3 B and
C). Foxp3
+Helios
+ cellsincreased approximately 3-foldover the first
24 hours p.i. in BALB/c mice, but not in CBA/Ca mice (p,0.001),
indicating that BALB/c T regulatory cells are activated rapidly
following infection. By contrast, there was no significant increase in
Foxp3
+Helios
negative cells in the lungs of either BALB/c or CBA/Ca
mice over the course of the infection (data not shown). The increase
in T regulatory cells in BALB/c lungs following infection is rapid,
supporting a greater role for nTregs than for iTregs, which can take
several days to differentiate in the periphery in response to TGF-b
and low doses of antigen.
To assess whether lung T regulatory cells actively secrete
immunomodulatory cytokines during pneumococcal infection, the
number of IL-10
+ T regulatory cells was assessed (Figure 3 D). T
regulatory cell-derived IL-10 has an important role in determining
resistance or susceptibility to infection against a range of pathogens
[26–27] and has been shown to influence susceptibility to disease
in pneumococcal pneumonia [28]. In our study, a significant
increase in IL-10
+ T regulatory cells was readily apparent in both
BALB/c (p,0.01) and CBA/Ca (p,0.05) mice compared to PBS
controls at 24 hours p.i. However, the number of IL-10
+ T
regulatory cells in BALB/c mice was significantly higher than in
infected CBA/Ca mice (p,0.05).
In addition to IL-10, several other markers – including PD-L1
[29] and CTLA-4 [30] - have been suggested to play a role in T
regulatory cell immunosuppressive functions. We assessed expres-
sion of PD-L1 and CTLA-4 by T regulatory cells in the lungs of
BALB/c and CBA/Ca mice. We observed barely detectable
expression of PD-L1 on T regulatory cells from either BALB/c or
CBA/Ca mice (data not shown) and low-level expression of
CTLA-4 on the majority of T regulatory cells from both strains
(data not shown). However, we also observed a population of
CTLA-4
high T regulatory cells in both strains of mice (Figure 3 E).
There was a significant difference in CTLA-4
high T regulatory cell
numbers between BALB/c and CBA/Ca mice at 24 hours p.i.
(p,0.001), with BALB/c lungs containing substantially more
CTLA4
high cells (Figure 3 E). This increase in CTLA-4
high T
regulatory cells in BALB/c mice could also be observed in the
spleen at 24 hours p.i. (Figure S2), suggesting the presence of a
circulating population of highly suppressive T cells. This result
further highlights the strong regulatory environment generated in
BALB/c mice following infection.
To rule out the possibility that the differences in TGF-b
signaling between BALB/c and CBA/Ca mice were affecting
Figure 3. IL-10-producing natural T regulatory cells are rapidly recruited to the lung in S. pneumoniae-infected BALB/c mice. All
results are from intranasal-infection of mice with wild-type S. pneumoniae D39. (A) Foxp3 immunostaining of lung sections taken from BALB/c and
CBA/Ca mice during pneumococcal infection. Inset shows example staining from 12 hour p.i. BALB/c mouse. Foxp3
+ cells stain brown. (B) Number of
Foxp3
+ T regulatory cells, (C) Number of Foxp3
+Helios
+ cells, (D) number of Foxp3
+IL-10
+ cells and (E) number of Foxp3
+CTLA-4
+ cells per mg lung in
S. pneumoniae-infected BALB/c and CBA/Ca mice, as identified by flow cytometry. Data in (D) are from 24 hrs p.i., PBS group contains both BALB/c
and CBA/Ca mice. White bars=BALB/c, black bars=CBA/Ca. *’s indicate significant difference, where *=p,0.05, **=p,0.01, and ***=p,0.005. For
all graphs data represent mean +/2 SEM. All results are representative of between 2–4 independent experiments with .4 mice per group.
doi:10.1371/journal.ppat.1002660.g003
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production of IL-17 was assessed in the lungs of BALB/c and
CBA/Ca mice at 24 hours p.i. (Figure S3). We observed only a
small population of IL-17
+ cells in either mouse strain and no
significant difference in CD4
+IL-17
+ cells was observed.
CBA/Ca mice show increased interferon gamma and
increased cellular apoptosis during pneumococcal
pneumonia
The strong immunomodulatory environment generated in
BALB/c lungs during pneumococcal pneumonia accounts for the
lower levels of pro-inflammatory cytokine seen in these mice p.i.
(Figure 4). Production of interferon (IFN)-c in CBA/Ca lungs at
24 hoursp.i.wassignificantlyhigherthaninBALB/clungs(p,0.05)
(Figure 4 A), and over 90% of NKp46
+ NK cells were found to be
IFN-c
+, as compared to 30–50% in BALB/c mice (Figure 4 B). NK
cells accounted for over 80% of IFN-c-producing cells in both
BALB/c and CBA/Ca mice, with the remaining 20% coming from
an unidentified CD45
+CD4
2CD8
2NKp46
2 cell type (data not
shown). The higher levels of IFN-c production in CBA/Ca mice
suggests that mechanisms limiting pro-inflammatory cytokine pro-
duction are more effective inBALB/cthan inCBA/Calungs during
pneumococcal pneumonia. IFN-c is known to induce apoptosis in a
range of cell types including lung epithelial cells [31,32] and so it is
possible that modulation of IFN-c production is one mechanism by
which T regulatory cells may help maintain epithelial barrier
integrity and confine the bacterial infection to the lung.
Intriguingly, the immunomodulation occurring in BALB/c
lungs at early time-points following infection appears to be a
specific process rather than a general dampening of immune
responses as BALB/c mice generate strong neutrophil responses in
the lung following intra-nasal infection (Figure S4 A) that are
thought to be critical in bacterial clearance [22]. Little influx of
neutrophils is observed in CBA/Ca mice over the first 24 hours
p.i. and so this response must be absent or else occurring after
bacteria have already disseminated to the blood stream (Figure S1
and Figure S4 A).
To determine whether reduced T regulatory cell numbers and
increased pro-inflammatory cytokine production correlated with
tissue damage in CBA/Ca mice, apoptosis was assessed in the
inflammatory loci within the lungs of S. pneumoniae-infected mice
(Figure 4 C). At 24 hours p.i., a time point at which BALB/c lungs
contain more T regulatory cells and less IFN-c than CBA/Ca
mice (Figure 3 A, B and Figure 4 A), a significantly higher
proportion of cells in the inflamed tissue had undergone apoptosis
in the lungs of CBA/Ca than in BALB/c mice (p,0.05) (Figure 4
C). At the same time p.i. (and 12 hrs previously), bacterial
dissemination from the lungs into the bloodstream had already
occurred in CBA/Ca mice, but not in BALB/c mice, which had
no septicaemia (Figure S1 B).
Inhibition of TGF-b1 impairs BALB/c resistance to
pneumococcal pneumonia
Having demonstrated differences in TGF-b production and T
regulatory cell activity over the course of infection in BALB/c and
CBA/Ca mice, we next investigated the potential of TGF-b1-
inhibition in BALB/c mice to influence their resistant phenotype
to pneumococcal pneumonia. If TGF-b had a significant role to
play in host defence against pneumonia, then inhibition of it would
render the BALB/c host more susceptible. A short synthetic
peptide (P17) was utilized to inhibit TGF-b activity in BALB/c
animals. The ability of P17 to effectively inhibit TGF-b1 and
TGF-b2 activity is well documented [33,34]. P17, or PBS as a
control, was administered to BALB/c mice 1 hour prior to
intranasal challenge with S. pneumoniae and then again at 6 hours
p.i. Strikingly, mice treated with the P17 peptide developed visible
signs of disease earlier than PBS-treated control animals and by
48 hours p.i. all ten P17-treated animals, but only one mouse from
the control group, displayed visible signs of disease (Figure 5 A).
Furthermore, 50% of P17-treated mice had to be culled due to
illness, while 100% of the control group survived (data not shown).
Although mice from both treatment groups showed similar lung
CFUs by 24 and 48 hours p.i., (Figure 5 B), P17-treated BALB/c
mice had significantly higher CFUs in their blood (Figure 5 C).
Figure 4. CBA/Ca mice display uncontrolled lung inflammation and associated apoptosis following S. pneumoniae infection. All
results are from intranasal-infection of mice with wild-type S. pneumoniae D39. (A) Number of IFNc
+NKp46
+CD4
2 cells per mg lung in PBS-treated or
S. pneumoniae-infected BALB/c and CBA/Ca mice at 24 hours p.i. (B) Top left shows gating of NK cells in lung homogenate. Remaining panels show
example IFNc-staining from PBS-treated CBA/Ca or S. pneumoniae-infected BALB/c and CBA/Ca mice at 24 hours p.i. (C) Proportion (%) of apoptotic
cells in areas of inflammation within lungs of S. pneumoniae-infected BALB/c and CBA/Ca mice. Inset shows apoptotic cell (arrow) within area of
inflammation as defined by presence of inflammatory infiltrate. White bars=BALB/c, black bars=CBA/Ca. *’s indicate significant difference, where
*=p,0.05 and ***=p,0.005. For all graphs data represent mean +/2 SEM. Results in (A and B) are representative of 3 independent experiments
with .4 mice per group. Results in (C) are from a single experiment with 5 mice per group. PBS-treated groups contained both BALB/c and CBA/Ca
mice.
doi:10.1371/journal.ppat.1002660.g004
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bacteraemia over the 48-hour experiment, 50% of the P17-treated
animals had substantial levels of bacteria in their blood by
48 hours p.i., indicating that inhibition of TGF-b promotes
bacterial seeding from lungs to blood. This is a key finding as
BALB/c mice intranasally infected with S. pneumoniae do not
develop septicaemia [22]. Therefore, in the absence of an effective
T regulatory cell and TGF-b response, resistant mice become
susceptible to pneumococcal pneumonia, developing sepsis (which
control mice do not) and substantially increased mortality.
As TGF-b is thought to be required for T regulatory cell
development, we investigated whether P17 treatment had had any
effect on T regulatory cell numbers in the lungs of infected BALB/
c mice. Analysis of Foxp3-stained lung sections from S. pneumoniae-
infected PBS-treated and P17-treated mice confirmed that P17
treatment substantially reduced numbers of Foxp3
+ cells in the
lungs of infected BALB/c mice at both 24 and 48 hours p.i., which
correlated with development of sepsis in these mice (Figure 5 D).
Adoptive transfer of T regulatory cells prolongs survival
of susceptible CBA/Ca mice
We next investigated whether increased numbers of T
regulatory cells in CBA/Ca mice might boost their resistance to
pneumococcal pneumonia. To generate sufficient numbers of cells
for adoptive transfer experiments, we differentiated inducible T
regulatory cells from CD4
+, CD25
negative T cells in vitro, by culture
with TGF-b in the presence of anti-CD3 and anti-CD28
stimulation. Whilst these cells have differentiation requirements
more similar to iTregs than nTregs, they share similar immuno-
suppressive qualities with nTregs, such as IL-10 production and
CTLA-4 expression [35]. The differentiation protocol yielded
approximately 90% CD4
+Foxp3
+ T regulatory cells, with a few
contaminating CD4
+Foxp3
negative T cells (Figure 6 A).
Adoptive transfer of in vitro generated CBA/Ca Foxp3
+ T
regulatory cells, via the tail vein, 2 hours prior to intranasal
infection with S. pneumoniae led to a significant increase in mean
survival of CBA/Ca mice (p,0.01) (Figure 6 B). By contrast,
CD4
+Foxp3
negative T cells generated in the same culture
conditions, but without TGF-b, and transferred into a separate
group of mice to control for contaminating T cells in the T
regulatory cell population, failed to increase survival (Figure 6 B).
At 24 hours p.i., a significant increase (p,0.01) in total T
regulatory cells (Figure 6 C) and IL-10
+ T regulatory cells (Figure 6
D) was observable in the lungs of mice that had received i.v.
administration of T regulatory cells, in contrast to mice that had
received PBS or CD4
+Foxp3
negative T cells i.v. This finding clearly
demonstrated an ability of the in vitro generated T regulatory cells
to influence immune responses, leading to increased host survival,
following transfer into the tail vein. Crucially, the bacterial load in
blood at 24 hours p.i. was significantly lower in mice that had
received T regulatory cells than either of the other two treatment
groups (p,0.001) (Figure 6 E). This suggests reduced translocation
of pneumococci from lungs to blood during pneumonia as a result
of T regulatory cell activity. This is a significant result as the CBA/
Ca strain is highly susceptible to invasive pneumococcal
pneumonia, and yet transfer of T regulatory cells alone was
Figure 5. Inhibition of TGF-b activity impairs BALB/c resistance to pneumococcal infection. All results are from intranasal-infection of
mice with wild-type S. pneumoniae D39. (A) Mean animal disease score in S. pneumoniae-infected PBS-treated or P17-treated BALB/c mice over a
48 hour time-course. Normal mice score 1. (B) Number of bacteria per mg lung tissue and (C) per ml blood in P17- (m) or PBS-treated (#) mice.
CFU=colony forming units. (D) Quantification of Foxp3
+ immunostaining in antibody-stained lung sections from P17- (black bars) or PBS-treated
(white bars) S. pneumoniae-infected mice. *’s indicate significant difference, where *=p,0.05 and **=p,0.01. For all graphs data represent mean +/
2 SEM. Results in (A–D) are representative of 2 independent experiments with .5 mice per group.
doi:10.1371/journal.ppat.1002660.g005
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survival and decreased seeding of bacteria to blood in CBA/Ca
mice that had received T regulatory cells correlated with a
decrease in the number of IFN-c
+ cells in the lungs, suggesting an
improved generation of an immunomodulatory environment in
these mice (Figure 6 F). The decreased levels of pro-apoptotic IFN-
c in these mice may contribute to the decreased seeding of bacteria
from lungs to blood (Figure 6 E).
Resistance to invasive pneumococcal pneumonia in
outbred mice correlates with strong T regulatory cell
responses
To test the hypothesis that strong T regulatory cell responses
correlate with resistance to pneumococcal pneumonia in other
mouse strains as well, we infected outbred MF1 mice and assessed
the progression of disease in relation to T regulatory cell activity
(Figure 7). At 48 hours p.i., mice showing visible signs of disease
were considered to have invasive pneumonia (Figure 7 A). The
remaining mice, which showed no disease signs, were deemed to
have ‘‘controlled infection’’ or non-invasive pneumonia. This was
confirmed by analysis of bacteraemia at 48 hours p.i., as all mice
which showed visible signs of disease had bacteria in their blood
compared with no bacteraemia in mice in the non-invasive
pneumonia group (Figure 7 B). Strikingly, the resistant phenotype
correlated with significantly higher numbers of T regulatory cells
in the lungs of mice from the non-invasive pneumonia group as
compared to the invasive pneumonia group at 48 hours p.i.
(p,0.05) (Figure 7 C). Intriguingly, neutrophil numbers in the
lungs of the invasive pneumonia group were significantly higher
than in the non-invasive pneumonia group at the same time point
(p,0.05) (Figure 7 D), suggesting that neutrophil influx alone is
insufficient to mediate resistance to infection in the absence of
protective T regulatory cell responses.
Discussion
Collectively, these data demonstrate an important role for T
regulatory cell activity in mediating resistance to pneumococcal
pneumonia. Thus, the differing susceptibilities of BALB/c and
CBA/Ca mice can be attributed in large part to differences in the
co-ordination and regulation of TGF-b signaling pathways in these
mice.
Evidence from other diseases suggests that CD4
+Foxp3
+ T
regulatory cells play prominent roles in immune suppression [36].
Indeed, in some infectious diseases, down-regulation of T
regulatory cells by pathogens is a feature of infection that
correlates with poor prognosis [37]. It is well known that infection
with S. pneumoniae results in a rapid and vigorous immune response
in the lungs characterized by early infiltration of neutrophils and
increased macrophage numbers [38] followed by an influx of
lymphocytes [39], but an uncontrolled and sustained influx of pro-
inflammatory leukocytes to the lung would be highly detrimental
to the host. Excessive inflammatory infiltrate can lead to
Figure 6. Adoptive transfer of in vitro generated Foxp3
+ T regulatory cells improves CBA/Ca survival in pneumococcal infection. (A)
CD4 and Foxp3 FACS staining of isolated CBA/Ca CD4
+, CD25
2 splenocytes before (left column) and after (right column) 5 days culture with anti-CD3,
anti-CD28 and TGF-b. 5 day cultured cells were used for adoptive transfer. All results in (B–D) are from intranasal-infection of mice with wild-type D39
S. pneumoniae. (B) Survival of S. pneumoniae-infected CBA/Ca mice that had received PBS (&), CD4
+ T cells (#), or T regulatory cells (.) i.v. prior to
intranasal infection with S. pneumoniae. Survival of T regulatory cell treatment group is significantly different to both CD4
+ T cell treatment group
(p,0.01) and PBS treatment group (p,0.01) (C) Number of Foxp3
+ cells and (D) number of IL-10
+Foxp3
+ cells per mg lung at 24 hours p.i. (E) Number
of bacteria/ml blood at 24 hour post-infection. (F) Number of IFN-c
+ cells per mg lung at 24 hours p.i.. CFU=colony forming units. I.N.=Intranasal.
I.V.=Intravenous. *’s indicate significant difference, where *=p,0.05 and ***=p,0.001. For all graphs data represent mean +/2 SEM. Results in (A)
are representative of 5 independent experiments. Results in (B–F) are representative of two independent experiments with .6 mice per group.
doi:10.1371/journal.ppat.1002660.g006
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enzymes and other soluble mediators released from the infiltrating
cells and such tissue damage could compromise the integrity of the
epithelial cell barrier of the lung and aid bacterial dissemination to
the bloodstream. Therefore, appropriately regulated immune
responses in the lung during pneumococcal infection are essential,
Figure 7. Disease resistance in outbred MF1 mice correlates with strong T regulatory cell responses in the lung. All results are from
intranasal-infection of outbred MF1 mice with wild-type S. pneumoniae D39. (A) Animal disease score at 48 hours p.i. A score of 1 is a normal mouse.
Any infected mouse scoring 1 at 48 hours p.i. was considered to have a controlled infection. (B) Number of bacteria/ml blood at 48 hours p.i.
CFU=colony forming units. Number of Foxp3
+ T regulatory cells (C) and Gr-1
hiF4/80
lo neutrophils (D) per mg lung in PBS-treated or S. pneumoniae-
infected MF1 mice at 48 hours p.i., as identified in flow cytometry. *’s indicate significant difference, where *=p,0.05 and **=p,0.01. For all graphs
data represent mean +/2 SEM. Results are representative of 2 independent experiments, each with 3 PBS-treated and .10 infected mice.
doi:10.1371/journal.ppat.1002660.g007
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role in this.
It appears that, in the absence of rapid T regulatory cell
induction in CBA/Ca mice, bacteria disseminate into the blood
stream before a regulated inflammatory environment of infiltrating
leukocytes has been established. By contrast, such an environment
is generated as early as 12 hours p.i. in BALB/c mice which likely
helps to contain the bacteria within the lungs and eventually clear
them. T regulatory cells in such an environment might limit the
inflammatory reaction in order to prevent tissue damage and
preserve epithelial barrier integrity. In CBA/Ca mice, with fewer
T regulatory cells, less TGF-b and no immunosuppression, this
process is inefficient and may lead to compromise of the lung
architecture. This is supported by the substantially increased levels
of apoptosis within the lungs of CBA/Ca mice, and increased
levels of bacterial seeding into blood.
The correlation between strong T regulatory cell responses and
decreased IFN-c production has been made previously. A recent
study outlined a correlation between increased Foxp3
+ T
regulatory cells in Malawian adults (with asymptomatic HIV
infection) and an associated skewing of T cell cytokine production
away from IFN-c [40]. In our study, the T cell contribution to
IFN-c production was minimal but we did observe reduced NK
cell-derived IFN-c in BALB/c mice, which have strong T
regulatory cell responses.
The finding that pneumococcal pneumonia induces IL-10
production in the lung is a significant one. T regulatory cell-
derived IL-10 has a well-documented role in immune homeostasis
in the lung during allergy. For example, mice in which IL-10 was
specifically ablated in T regulatory cells displayed perivasculitis
and mononuclear cell infiltration around the large airways of the
lung [41]. The same mice also displayed exacerbated disease signs
in an ovalbumin-driven model of allergic airways inflammation.
Thus, it appears that T regulatory cell-derived IL-10 plays an
important role in the suppression of immunological reactivity in
the lung in the context of both allergic inflammation and infection,
where it may help limit infection-related tissue damage. In
addition to IL-10 production, the T regulatory cells induced in
response to pneumococcal infection might mediate immune
regulation and the suppression of pathological inflammatory
responses through a direct cell-cell contact mechanism. The
finding that CTLA-4 is highly expressed on a subset of T
regulatory cells in resistant BALB/c, but not susceptible CBA/Ca
mice following pneumococcal infection supports this assertion.
Interestingly, our studies in outbred MF1 mice provided
complementary evidence for a link between resistance to invasive
disease and high lung regulatory T cell numbers but also suggested
that uncontrolled lung neutrophil influx in susceptible mice might
contribute to lung tissue damage that promotes bacterial
dissemination. A similar destructive role for neutrophils has been
suggested previously after it was demonstrated that depletion of
neutrophils with monoclonal antibodies could prolong survival in
mice given a lethal intranasal dose of serotype 8 pneumococci
[42]. Furthermore, the detrimental effects of excessive neutrophil
recruitment have been documented recently in a study investigat-
ing sex-based differences in susceptibility to pneumococcal disease
[43]. The greater susceptibility of male mice to invasive
pneumococcal disease was attributed in part to the uncontrolled
presence of pro-inflammatory cytokines and greater neutrophil
infiltration into lungs following respiratory pneumococcal infection
as compared to reduced pro-inflammatory cytokines and lower
neutrophil infiltration in lungs of female mice. However, these
data must be balanced against the proven role for neutrophils in
bacterial clearance. It is likely that it is the timing of the neutrophil
influx that is crucial [1–3,22]. If recruitment can occur whilst the
bacteria are still confined to the lung then disease resolution may
occur, but if the influx occurs later, the neutrophils may fail to
clear the infection and may aid bacterial dissemination via
contribution to lung damage. The earlier influx of neutrophils to
the lungs in BALB/c versus CBA/Ca mice certainly correlates
with bacterial clearance.
Collectively, these findings dramatically alter our perception of
host immune responses to pneumococcal infection, emphasizing
the importance of balancing pro-inflammatory responses in the
lung with controlled anti-inflammatory and immunomodulatory
activity. Furthermore, it is clear that achieving this balance is
fundamental to containment and clearance of pneumococcal
infection in lungs. The finding that the correlation between strong
regulatory cell responses and invasive disease resistance is not
restricted to BALB/c and CBA/Ca mice but can also be observed
in outbred MF1 mice is an important one, as these genetically
variable populations mimic more closely the spectrum of disease
resistance phenotypes seen in human populations. In this paper we
show how differences in the regulation and balance of host
immune responses can dramatically alter the development and
outcome of infection by either leading to containment and
clearance of the pathogen from lungs or the development of
severe invasive pneumonia and lethal septicaemia. It follows that
genetic differences in components of immunomodulatory path-
ways may predispose individuals to the development of septicae-
mia following acute pneumonia. An improved understanding of
the mechanisms operating in the lungs and the role that regulatory
cells and cytokines play in these processes may allow us to predict
outcomes of infection and tailor treatments accordingly. It will also
certainly be of interest to develop novel pneumococcal vaccines
that can induce protective T regulatory cell responses.
Methods and Materials
Ethics statement
This study was performed in strict accordance with U.K. Home
Office guidelines. The protocol was approved by both the U.K.
Home Office and the University of Leicester ethics committee.
Every effort was made to minimize suffering and in bacterial
infection experiments mice were humanely culled if they became
lethargic. All animal experiments were carried out at the
University of Leicester.
Mice
Female BALB/cOlaHsd (abbreviated to BALB/c), CBA/
CaOlaHsd (CBA/Ca) and MF1 mice were purchased from
Harlan Laboratories (Bicester, UK) and were acclimatised for
two weeks prior to use. Mice used for infection experiments were
between 9 and 14 weeks of age and were age matched for each
experiment. The University of Leicester Ethical Committee and
the U.K. Home Office approved the experimental protocols.
Bacteria
Streptococcus pneumoniae strain D39 (NCTC 7466) was used for
infection. D39 is a mouse virulent serotype 2 strain. Bacteria were
identified as pneumococci by the Gram stain, catalase test, a-
haemolysis on blood agar and by optochin sensitivity. Presence of
capsule was confirmed via quellung reaction. Before use in
infection studies, bacteria were passaged through mice to
standardize the inoculum and were stored at 280uC. When
required, suspensions were thawed at room temperature and the
infectious dose prepared as described previously [4].
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Animals were anaesthetised with a mixture of O2 and
isofluorane and infected intranasally with 1610
6 CFU S. pneumo-
niae, as described previously [4]. Mice were periodically scored for
clinical signs of disease and were culled when they became severely
lethargic or else at pre-determined times post-infection. Signs of
disease were scored based on the scheme of Morton [44]. Mice
were culled by cervical dislocation and the lungs were removed
and snap frozen in liquid nitrogen or else prepared for flow
cytometry by incubation for 30 minutes at 37 degrees with
10 mg/ml collagenase D (Amersham), homogenization and lysis of
erythrocytes. Blood samples were taken by cardiac puncture under
terminal anaesthesia or from tail-bleeds.
RNA amplification and labelling for microarray
RNA was pooled for each strain (5 mice per pool). RNA
samples were amplified and labelled using the Ambion Amino
Allyl MessageAmp aRNA Amplification kit. For each sample 2 mg
total RNA was amplified and labelled according to the
manufacturer’s instructions. Universal Mouse Reference RNA
(Stratagene) was used as a reference for gene-profiling.
Microarray
Samples were hybridized to microarray slide sets consisting of
31,769 oligonucleotides (70mers) from the Array Reagy Oligo set for
the Mouse Genome Version 3 (Qiagen). The oligos were distributed
over 3 slides and were spotted on codelink slides (Amersham
Biosciences) using the Amersham Lucidea spotter. Slides were
scanned using the GenePix Pro 4000B scanner (Axon) and Genepix
pro 4.1 software. Spots were flagged if the fluorescent signal from a
particularspot wasno higher thanthe local background fluorescence
or if there was more than a 10% difference in the mean and median
intensity of a feature. Signal intensity data were scaled to the
reference channel and analysed using the ‘‘linear models for
microarray data’’ software Limma in the BioConductor package
for R (http://bioconductor.org/biocLite.R).
Ingenuity Pathway Analysis (IPA)
IPA software (www.ingenuity.com) was used to explore
pathways and relationships between genes of interest in a data set.
qRT-PCR
cDNA was synthesised from RNA using TaqMan Reverse
Transcription reagents kit, as per the manufacturer’s instructions
(Applied Biosystems N808-0234). Real time qRT-PCR was
performed using Taqman chemistry. The Taqman assays were
pre-made validated FAM-labelled primer-probe sets from
Applied Biosystems (for hprt1, Mm00446968_m1; for tgfb1,
Mm03024053_m1). Each sample and assay was performed in
triplicate. The PCR reactions were run on an ABI Prism 7500
FAST system (Applied Biosystems) using the standard conditions
for Taqman assays. Results were normalised to the house keeping
gene hprt1 and analysed using the 2
2DDCt method. For the t=0
samples the sham and infected for each strain were combined and
the CBA/Ca samples were compared to the BALB/c samples (the
calibrator) to give the fold change (2
2DDCt) difference. For the t=6
and t=12 samples the infected were compared to the sham (the
calibrator) for each sample to calculate the fold change (2
2DDCt)i n
response to infection.
Determination of bacterial numbers in lung and blood
The viable count of bacteria in blood and lungs was determined
at the pre-chosen intervals after intranasal infection. Viable counts
in lung cell suspension and in blood samples were determined by
serial dilution in sterile 16 PBS and plating on blood agar
containing 5% (v/v) defibrinated horse blood (Oxoid). Once dry,
plates were incubated in 5% (v/v) CO2 at 37uC overnight and
bacterial colony numbers assessed the following day.
P17 peptide challenge
500 mg P17 peptide in 100 ml PBS was administered by
intraperitoneal (i.p.) injection 1 hour before and 6 hours after
intranasal challenge with wild type D39 S. pneumoniae. Control
animals received i.p. injections of PBS as a control.
Flow cytometry
Mouse tissue cell suspensions, at 2610
8 cells/ml were incubated
with purified anti-Fc receptor blocking antibody (anti-CD16/
CD32) before addition of the specific antibodies. Cell surface
markers were stained using a combination of fluorescein
isothiocyanate (FITC)-, phycoerythrin (PE)-, PE-Cy7- and allo-
phycocyanin (APC)-conjugated monoclonal antibodies. Intracel-
lular staining with monoclonal antibodies for Foxp3, Helios, IL-10
and IFN-c was performed according to the manufacturer’s
instructions (eBioscience). In each experiment the appropriate
isotype control monoclonal antibodies and single conjugate
controls (eBioscience) were also included. Samples were analysed
using a Becton Dickinson FACScalibur flow cytometer running
CellQuest acquisition and analysed using FlowJo software (version
8.8.3, Tree Star).
T regulatory cell culture
CD4
+ CD25
2 T cells were isolated from CBA/Ca spleens by a
combination of magnetic depletion and positive selection for CD4,
according to manufacturer’s instructions (Stemcell Technologies).
Cells were cultured at a density of 2610
6 cells/ml in 24-well plates
for 5 days in X-Vivo15 serum-free medium supplemented with
anti-CD28 (2 mg/ml), plate-bound anti-CD3 (10 mg/ml), and
TGF-b1 (5 ng/ml) to induce differentiation of Foxp3
+ CD25
+ T
regulatory cells [35]. CD4
+ T cells cultured as controls were
subjected to the same culture conditions but without TGF-b1.
Adoptive transfer
100 mlo fin vitro generated CD4
+ CD25
+ Foxp3
+ T regulatory
cells (3610
6/ml)insterile PBS wasadoptively transferred intoCBA/
Ca mice via injection into the tail vein, 2 hours prior to intranasal
infection with S. pneumoniae. Control CBA/Ca mice received either
100 mls t e r i l eP B So r1 0 0mlC D 4
+ Tc e l l s( 3 610
6/ml) i.v.
Preparation and analysis of lung tissue section
At necropsy, tissue samples were immersed in 10% v/v formalin
saline solution prior to conventional processing and embedding in
paraffin wax. Histopathological assessment was performed on
tissue sections stained with hematoxylin and eosin (BDH) or
Giemsa. Foxp3 staining was performed using antibody clone FJK-
16s (eBioscience) and streptavidin horseradish peroxidase chem-
istry following standard protocols (DAKO). TGFB1 immunostain-
ing was performed with a polyclonal rabbit antibody (Sc-146,
Santa Cruz). Counting was performed double-blind using 3 slides
per lung per timepoint and 4–5 lungs per timepoint for each strain.
Counting was performed on computer on a captured image of the
slide.
Quantification of apoptosis in lung tissues
Rabbit anti-active caspase polyclonal antibody (AF835, R&D
systems) was used as a marker of apoptosis. Biotinylated anti-rabbit
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detected using the Vectastain elite ABC kit (Vector labs). The
antibody complex was visualized by the hydrogen peroxide-
diaminobenzidene (DAB) reaction, producing a brown end
product. Slides were counterstained with hematoxylin prior to
examination by light microscopy. The number of brown-staining
apoptotic cells were expressed as a percentage of total cells as
assessed by number of blue-staining nuclei. Lung tissue was split
into alveolar, airway and inflammatory areas and the three regions
counted separately. Counting was performed double-blind using 3
slides per lung per timepoint and 4–5 lungs per timepoint for each
strain. A minimum of 200 cells were counted per slide and
counting continued until either at least 20 positive cells were
counted or a maximum of 3000 counted cells was reached.
Counting was performed on computer on a captured image of the
slide.
Statistics
Data were analysed using a two-tailed unpaired Student T test
or one- or two-way ANOVA, as appropriate. Results with p-values
less than 0.05 were considered significant. Statistical analysis was
performed with the aid of Graph Pad Prism.
Supporting Information
Figure S1 BALB/c mice control S. pneumoniae infection
whilst CBA/Ca mice do not. BALB/c and CBA/Ca mice
were intranasally-infected with wild type D39 S. pneumoniae and
lung (A) and blood (B) bacterial numbers assessed at 0, 12 and
24 hours p.i. Data are representative of .10 independent
experiments with at least 5 mice per group. Data represent mean
+/2 SEM.
(TIF)
Figure S2 CTLA-4high T regulatory cells increase
following S. pneumoniae infection in BALB/c but not
CBA/Ca mice. BALB/c and CBA/Ca mice were intranasally-
infected with wild type D39. Data are from a single experiment
with 4 mice per group per time point. White bars=BALB/c.
Black bars=CBA/Ca. Data represent mean +/2 SEM.
***=p,0.001.
(TIF)
Figure S3 There is no significant difference in IL-17+
cell numbers in BALB/c or CBA/Ca lungs at 24 hours
post-infection. BALB/c and CBA/Ca mice were intranasally-
infected with wild-type D39 or PBS as a control. PBS group
contains BALB/c and CBA/Ca animals. Data are representative
of two independent experiments with .4 mice per group. IL-17+
cell number was assessed by flow cytometry. ns=not significant.
(TIF)
Figure S4 Neutrophils and macrophages increase sig-
nificantly in BALB/c but not CBA/Ca lungs following
infection. (A) PMN (Gr-1+, F4/80low) and (B) macrophage (F4/
80high) number per mg lung as assessed by flow cytometry.
*=p,0.05, **=p,0.01, ***=p,0.001. Data are representative
of two independent experiments with .5 mice per group per time
point.
(TIF)
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